Hyperhomocysteinemia induces cardiac injury by up-regulation of p53-dependent Noxa and Bax expression through the p53 DNA methylation in ApoE-/- mice

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 5, 2013, Pages 391-400

  Ma, Shengchao ^a   Zhang, Huiping ^a   Sun, Weiwei ^a   Gong, Huihui ^a   Wang, Yanhua ^a   Ma, Changjian ^a   Wang, Ju ^a   Cao, Chengjian ^a   Yang, Xiaoling ^a   Tian, Jue ^a   Jiang, Yideng ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac injury; DNA methylation; Hyperhomocysteinemia; p53

Indexed keywords

APOLIPOPROTEIN E; CASP3 PROTEIN, MOUSE; CASPASE 3; CASPASE 9; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; PMAIP1 PROTEIN, MOUSE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMAL; ARTICLE; BIOSYNTHESIS; CARDIOMYOPATHY; DNA METHYLATION; GENETICS; HYPERHOMOCYSTEINEMIA; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; UPREGULATION;

ANIMALS; APOLIPOPROTEINS E; BCL-2-ASSOCIATED X PROTEIN; CARDIOMYOPATHIES; CASPASE 3; CASPASE 9; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; HYPERHOMOCYSTEINEMIA; MALE; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

MUS;

EID: 84879222276     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt030     Document Type: Article

References (35)

1. Beard RS Jr and Bearden SE. Vascular complications of cystathionine b-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol 2011, 300: H13-H26.
2. Maldonado C, Soni CV, Todnem ND, Pushpakumar S, Rosenberger D, Givvimani S and Villafane J, et al. Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms. Curr Vasc Pharmacol 2010, 8: 64-74.
3. Moshal KS, Metreveli N, Frank I and Tyagi SC. Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia. Curr Vasc Pharmacol 2008, 6: 84-92.
4. Misra A, Haudek SB, Knuefermann P, Vallejo JG, Chen ZJ, Michael LH and Sivasubramanian N, et al. Nuclear factor-kB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 2003, 108: 3075-3078.
5. Feridooni T, Hotchkiss A, Remley-Carr S, Saga Y and Pasumarthi KB. Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes. PLoS One 2011, 6: e22801.
6. Shankar S and Srivastava RK. Involvement of Bcl-2 family members, phosphatidylinositol 30-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol 2007, 30: 905-918.
7. Halasova E, Adamkov M, Matakova T, Vybohova D, Antosova M, Janickova M, Singliar A and Dobrota D, et al. Expression of Ki-67, Bcl-2, survivin and p53 proteins in patients with pulmonary carcinoma. Adv Exp Med Biol 2013, 756: 15-21.
8. Gryko M, Pryczynicz A, Guzińska-Ustymowicz K, Kamocki Z, Zareba K, Kemona A and Kedra B. Immunohistochemical assessment of apoptosis-associated proteins: p53, Bcl-xL, Bax and Bak in gastric cancer cells in correlation with clinical and pathomorphological factors. Adv Med Sci 2012, 71: 77-83.
9. Schuler M, Maurer U, Goldstein JC, Breitenbu?cher F, Hoffarth S, Waterhouse NJ and Green DR. p53 triggers apoptosis in oncogeneexpressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death Differ 2003, 10: 451-460.
10. Chen NC, Yang F, Capecci LM, Gu Z, Schafer AI, Durante W, Yang XF and Wang H. Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J 2010, 24: 2804-2817.
11. Anderson OS, Sant KE and Dolinoy DC. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem 2012, 23: 853-859.
12. Jiang Y, Zhang H, Sun T, Wang J, Sun W, Gong H and Yang B, et al. The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE2/2 mice. Acta Biochim Biophys Sin 2012, 44: 866-875.
13. Arand J, Spieler D, Karius T, Branco MR, Meilinger D, Meissner A and Jenuwein T, et al. In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases. PLoS Genet 2012, 8: e1002750.
14. Esposito E, Rinaldi B, Mazzon E, Donniacuo M, Impellizzeri D, Paterniti I and Capuano A, et al. Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-a. J Neuroinflammation 2012, 9: 81.
15. Wang X, Cui L, Joseph J, Jiang B, Pimental D, Handy DE and Liao R, et al. Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress. J Mol Cell Cardiol 2012, 52: 753-760.
16. Hsiao WT, Tsai MD, Jow GM, Tien LT and Lee YJ. Involvement of Smac, p53, and caspase pathways in induction of apoptosis by gossypol in human retinoblastoma cells. Mol Vis 2012, 18: 2033-2042.
17. Rooswinkel RW, van de Kooij B, Verheij M and Borst J. Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B. Cell Death Dis 2012, 3: e366.
18. Jullig M, Zhang WV, Ferreira A and Stott NS. MG132 induced apoptosis is associated with p53-independent induction of pro-apoptotic Noxa and transcriptional activity of beta-catenin. Apoptosis 2006, 11: 627-641.
19. Clements EG, Mohammad HP, Leadem BR, Easwaran H, Cai Y, Van Neste L and Baylin SB. DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes. Nucleic Acids Res 2012, 40: 4334-4346.
20. Lin HC, Hsieh HM, Chen YH and Hu ML. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters. Neurotoxicology 2009, 30: 622-627.
21. Zhang J, Handy DE, Wang Y, Bouchard G, Selhub J, Loscalzo J and Carey MC. Hyper- homocysteinemia from trimethylation of hepatic phosphatidylethanolamine during cholesterol cho- lelithogenesis in inbred mice. Hepatology 2011, 54: 697-706.
22. Sipkens JA, Hahn NE, Blom HJ, Lougheed SM, Stehouwer CD, Rauwerda JA and Krijnen PA, et al. S-Adenosylhomocysteine induces apoptosis and phosphatidylserine exposure in endothelial cells independent of homocysteine. Atherosclerosis 2012, 221: 48-54.
23. Henning RJ, Dennis S, Sawmiller D, Hunter L, Sanberg P and Miller L. Human umbilical cord blood mononuclear cells activate the survival protein Akt in cardiac myocytes and endothelial cells that limits apoptosis and necrosis during hypoxia. Transl Res 2012, 159: 497-506.
24. Li YC, Ge LS, Yang PL, Tang JF, Lin JF, Chen P and Guan XQ. Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction. Eur J Pharmacol 2010, 640: 112-116.
25. Silva-Platas C, García N, Fernandez-Sada E, Davila D, Hernandez-Brenes C, Rodriguez D and García-Rivas G. Cardiotoxicity of acetogenins from Persea americana occurs through the mitochondrial permeability transition pore and caspase-dependent apoptosis pathways. J Bioenerg Biomembr 2012, 44: 461-471.
26. Ghobrial IM, Witzig TE and Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005, 55: 178-194.
27. Qiao S, Cabello CM, Lamore SD, Lesson JL and Wondrak GT. D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis 2012, 17: 1079-1094.
28. Liu P, Xu B, Cavalieri TA and Hock CE. Inhibition of p53 by pifithrin-alpha reduces myocyte apoptosis and leukocyte transmigration in aged rat hearts following 24 hours of reperfusion. Shock 2008, 5: 545-551.
29. Lee SJ, Kim KM, Namkoong S, Kim CK, Kang YC, Lee H, Ha KS and Han JA, et al. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem 2005, 280: 5781-5788.
30. Stegh AH and DePinho RA. Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma. Cell Cycle 2011, 10: 33-38.
31. Kovacheva VP, Mellott TJ, Davison JM, Wagner N, Lopez-Coviella I, Schnitzler AC and Blusztajn JK. Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression. J Biol Chem 2007, 282: 31777-31788.
32. Tian K, Wang Y, Huang Y, Sun B, Li Y and Xu H. Methylation of WTH3, a possible drug resistant gene, inhibits p53 regulated expression. BMC Cancer 2008, 8: 327.
33. Setoguchi H, Namihira M, Kohyama J, Asano H, Sanosaka T and Nakashima K. Methyl-CpG binding proteins are involved in restricting differentiation plasticity in neurons. J Neurosci Res 2006, 84: 969-979.
34. Sukla KK and Raman R. Association of MTHFR and RFC1 gene polymorphism with hyper- homocysteinemia and its modulation by vitamin B12 and folic acid in an Indian population. Eur J Clin Nutr 2012, 66: 111-118.
35. Bhargava S, Ali A, Bhargava EK, Manocha A, Kankra M, Das S and Mohan Srivastava L. Lowering homocysteine and modifying nutritional status with folic acid and vitamin B12 in Indian patients of vascular disease. J Clin Biochem Nutr 2012, 50: 222-226.